Report Detail

Pharma & Healthcare Global Finasteride Oral Tablet Market Growth 2022-2028

  • RnM4389776
  • |
  • 04 March, 2022
  • |
  • Global
  • |
  • 108 Pages
  • |
  • LPI(LP Information)
  • |
  • Pharma & Healthcare

As the global economy mends, the 2021 growth of Finasteride Oral Tablet will have significant change from previous year. According to our (LP Information) latest study, the global Finasteride Oral Tablet market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Finasteride Oral Tablet market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.

The United States Finasteride Oral Tablet market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Finasteride Oral Tablet market, reaching US$ million by the year 2028. As for the Europe Finasteride Oral Tablet landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.

Global main Finasteride Oral Tablet players cover Merck, Accord Healthcare UK, Relonchem, and Sandoz, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Finasteride Oral Tablet market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
1mg Tablet
5mg Tablet

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Benign Prostatic Hyperplasia
Male Pattern Baldness
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Merck
Accord Healthcare UK
Relonchem
Sandoz
Teva Generics
Cipla
Dr. Reddy
Aurobindo Pharma
Henan Topfond
Zhejiang CONBA Pharmaceutical
Shandong Renhetang Pharmaceutical
Guangdong Eashu Pharmacetical
Shanghai Shyndec Pharmaceutical Co.,Ltd.


1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Finasteride Oral Tablet Annual Sales 2017-2028
    • 2.1.2 World Current & Future Analysis for Finasteride Oral Tablet by Geographic Region, 2017, 2022 & 2028
    • 2.1.3 World Current & Future Analysis for Finasteride Oral Tablet by Country/Region, 2017, 2022 & 2028
  • 2.2 Finasteride Oral Tablet Segment by Type
    • 2.2.1 1mg Tablet
    • 2.2.2 5mg Tablet
  • 2.3 Finasteride Oral Tablet Sales by Type
    • 2.3.1 Global Finasteride Oral Tablet Sales Market Share by Type (2017-2022)
    • 2.3.2 Global Finasteride Oral Tablet Revenue and Market Share by Type (2017-2022)
    • 2.3.3 Global Finasteride Oral Tablet Sale Price by Type (2017-2022)
  • 2.4 Finasteride Oral Tablet Segment by Application
    • 2.4.1 Benign Prostatic Hyperplasia
    • 2.4.2 Male Pattern Baldness
    • 2.4.3 Others
  • 2.5 Finasteride Oral Tablet Sales by Application
    • 2.5.1 Global Finasteride Oral Tablet Sale Market Share by Application (2017-2022)
    • 2.5.2 Global Finasteride Oral Tablet Revenue and Market Share by Application (2017-2022)
    • 2.5.3 Global Finasteride Oral Tablet Sale Price by Application (2017-2022)

3 Global Finasteride Oral Tablet by Company

  • 3.1 Global Finasteride Oral Tablet Breakdown Data by Company
    • 3.1.1 Global Finasteride Oral Tablet Annual Sales by Company (2020-2022)
    • 3.1.2 Global Finasteride Oral Tablet Sales Market Share by Company (2020-2022)
  • 3.2 Global Finasteride Oral Tablet Annual Revenue by Company (2020-2022)
    • 3.2.1 Global Finasteride Oral Tablet Revenue by Company (2020-2022)
    • 3.2.2 Global Finasteride Oral Tablet Revenue Market Share by Company (2020-2022)
  • 3.3 Global Finasteride Oral Tablet Sale Price by Company
  • 3.4 Key Manufacturers Finasteride Oral Tablet Producing Area Distribution, Sales Area, Product Type
    • 3.4.1 Key Manufacturers Finasteride Oral Tablet Product Location Distribution
    • 3.4.2 Players Finasteride Oral Tablet Products Offered
  • 3.5 Market Concentration Rate Analysis
    • 3.5.1 Competition Landscape Analysis
    • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
  • 3.6 New Products and Potential Entrants
  • 3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Finasteride Oral Tablet by Geographic Region

  • 4.1 World Historic Finasteride Oral Tablet Market Size by Geographic Region (2017-2022)
    • 4.1.1 Global Finasteride Oral Tablet Annual Sales by Geographic Region (2017-2022)
    • 4.1.2 Global Finasteride Oral Tablet Annual Revenue by Geographic Region
  • 4.2 World Historic Finasteride Oral Tablet Market Size by Country/Region (2017-2022)
    • 4.2.1 Global Finasteride Oral Tablet Annual Sales by Country/Region (2017-2022)
    • 4.2.2 Global Finasteride Oral Tablet Annual Revenue by Country/Region
  • 4.3 Americas Finasteride Oral Tablet Sales Growth
  • 4.4 APAC Finasteride Oral Tablet Sales Growth
  • 4.5 Europe Finasteride Oral Tablet Sales Growth
  • 4.6 Middle East & Africa Finasteride Oral Tablet Sales Growth

5 Americas

  • 5.1 Americas Finasteride Oral Tablet Sales by Country
    • 5.1.1 Americas Finasteride Oral Tablet Sales by Country (2017-2022)
    • 5.1.2 Americas Finasteride Oral Tablet Revenue by Country (2017-2022)
  • 5.2 Americas Finasteride Oral Tablet Sales by Type
  • 5.3 Americas Finasteride Oral Tablet Sales by Application
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC Finasteride Oral Tablet Sales by Region
    • 6.1.1 APAC Finasteride Oral Tablet Sales by Region (2017-2022)
    • 6.1.2 APAC Finasteride Oral Tablet Revenue by Region (2017-2022)
  • 6.2 APAC Finasteride Oral Tablet Sales by Type
  • 6.3 APAC Finasteride Oral Tablet Sales by Application
  • 6.4 China
  • 6.5 Japan
  • 6.6 South Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia
  • 6.10 China Taiwan

7 Europe

  • 7.1 Europe Finasteride Oral Tablet by Country
    • 7.1.1 Europe Finasteride Oral Tablet Sales by Country (2017-2022)
    • 7.1.2 Europe Finasteride Oral Tablet Revenue by Country (2017-2022)
  • 7.2 Europe Finasteride Oral Tablet Sales by Type
  • 7.3 Europe Finasteride Oral Tablet Sales by Application
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa Finasteride Oral Tablet by Country
    • 8.1.1 Middle East & Africa Finasteride Oral Tablet Sales by Country (2017-2022)
    • 8.1.2 Middle East & Africa Finasteride Oral Tablet Revenue by Country (2017-2022)
  • 8.2 Middle East & Africa Finasteride Oral Tablet Sales by Type
  • 8.3 Middle East & Africa Finasteride Oral Tablet Sales by Application
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

  • 10.1 Raw Material and Suppliers
  • 10.2 Manufacturing Cost Structure Analysis of Finasteride Oral Tablet
  • 10.3 Manufacturing Process Analysis of Finasteride Oral Tablet
  • 10.4 Industry Chain Structure of Finasteride Oral Tablet

11 Marketing, Distributors and Customer

  • 11.1 Sales Channel
    • 11.1.1 Direct Channels
    • 11.1.2 Indirect Channels
  • 11.2 Finasteride Oral Tablet Distributors
  • 11.3 Finasteride Oral Tablet Customer

12 World Forecast Review for Finasteride Oral Tablet by Geographic Region

  • 12.1 Global Finasteride Oral Tablet Market Size Forecast by Region
    • 12.1.1 Global Finasteride Oral Tablet Forecast by Region (2023-2028)
    • 12.1.2 Global Finasteride Oral Tablet Annual Revenue Forecast by Region (2023-2028)
  • 12.2 Americas Forecast by Country
  • 12.3 APAC Forecast by Region
  • 12.4 Europe Forecast by Country
  • 12.5 Middle East & Africa Forecast by Country
  • 12.6 Global Finasteride Oral Tablet Forecast by Type
  • 12.7 Global Finasteride Oral Tablet Forecast by Application

13 Key Players Analysis

  • 13.1 Merck
    • 13.1.1 Merck Company Information
    • 13.1.2 Merck Finasteride Oral Tablet Product Offered
    • 13.1.3 Merck Finasteride Oral Tablet Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.1.4 Merck Main Business Overview
    • 13.1.5 Merck Latest Developments
  • 13.2 Accord Healthcare UK
    • 13.2.1 Accord Healthcare UK Company Information
    • 13.2.2 Accord Healthcare UK Finasteride Oral Tablet Product Offered
    • 13.2.3 Accord Healthcare UK Finasteride Oral Tablet Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.2.4 Accord Healthcare UK Main Business Overview
    • 13.2.5 Accord Healthcare UK Latest Developments
  • 13.3 Relonchem
    • 13.3.1 Relonchem Company Information
    • 13.3.2 Relonchem Finasteride Oral Tablet Product Offered
    • 13.3.3 Relonchem Finasteride Oral Tablet Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.3.4 Relonchem Main Business Overview
    • 13.3.5 Relonchem Latest Developments
  • 13.4 Sandoz
    • 13.4.1 Sandoz Company Information
    • 13.4.2 Sandoz Finasteride Oral Tablet Product Offered
    • 13.4.3 Sandoz Finasteride Oral Tablet Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.4.4 Sandoz Main Business Overview
    • 13.4.5 Sandoz Latest Developments
  • 13.5 Teva Generics
    • 13.5.1 Teva Generics Company Information
    • 13.5.2 Teva Generics Finasteride Oral Tablet Product Offered
    • 13.5.3 Teva Generics Finasteride Oral Tablet Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.5.4 Teva Generics Main Business Overview
    • 13.5.5 Teva Generics Latest Developments
  • 13.6 Cipla
    • 13.6.1 Cipla Company Information
    • 13.6.2 Cipla Finasteride Oral Tablet Product Offered
    • 13.6.3 Cipla Finasteride Oral Tablet Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.6.4 Cipla Main Business Overview
    • 13.6.5 Cipla Latest Developments
  • 13.7 Dr. Reddy
    • 13.7.1 Dr. Reddy Company Information
    • 13.7.2 Dr. Reddy Finasteride Oral Tablet Product Offered
    • 13.7.3 Dr. Reddy Finasteride Oral Tablet Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.7.4 Dr. Reddy Main Business Overview
    • 13.7.5 Dr. Reddy Latest Developments
  • 13.8 Aurobindo Pharma
    • 13.8.1 Aurobindo Pharma Company Information
    • 13.8.2 Aurobindo Pharma Finasteride Oral Tablet Product Offered
    • 13.8.3 Aurobindo Pharma Finasteride Oral Tablet Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.8.4 Aurobindo Pharma Main Business Overview
    • 13.8.5 Aurobindo Pharma Latest Developments
  • 13.9 Henan Topfond
    • 13.9.1 Henan Topfond Company Information
    • 13.9.2 Henan Topfond Finasteride Oral Tablet Product Offered
    • 13.9.3 Henan Topfond Finasteride Oral Tablet Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.9.4 Henan Topfond Main Business Overview
    • 13.9.5 Henan Topfond Latest Developments
  • 13.10 Zhejiang CONBA Pharmaceutical
    • 13.10.1 Zhejiang CONBA Pharmaceutical Company Information
    • 13.10.2 Zhejiang CONBA Pharmaceutical Finasteride Oral Tablet Product Offered
    • 13.10.3 Zhejiang CONBA Pharmaceutical Finasteride Oral Tablet Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.10.4 Zhejiang CONBA Pharmaceutical Main Business Overview
    • 13.10.5 Zhejiang CONBA Pharmaceutical Latest Developments
  • 13.11 Shandong Renhetang Pharmaceutical
    • 13.11.1 Shandong Renhetang Pharmaceutical Company Information
    • 13.11.2 Shandong Renhetang Pharmaceutical Finasteride Oral Tablet Product Offered
    • 13.11.3 Shandong Renhetang Pharmaceutical Finasteride Oral Tablet Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.11.4 Shandong Renhetang Pharmaceutical Main Business Overview
    • 13.11.5 Shandong Renhetang Pharmaceutical Latest Developments
  • 13.12 Guangdong Eashu Pharmacetical
    • 13.12.1 Guangdong Eashu Pharmacetical Company Information
    • 13.12.2 Guangdong Eashu Pharmacetical Finasteride Oral Tablet Product Offered
    • 13.12.3 Guangdong Eashu Pharmacetical Finasteride Oral Tablet Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.12.4 Guangdong Eashu Pharmacetical Main Business Overview
    • 13.12.5 Guangdong Eashu Pharmacetical Latest Developments
  • 13.13 Shanghai Shyndec Pharmaceutical Co.,Ltd.
    • 13.13.1 Shanghai Shyndec Pharmaceutical Co.,Ltd. Company Information
    • 13.13.2 Shanghai Shyndec Pharmaceutical Co.,Ltd. Finasteride Oral Tablet Product Offered
    • 13.13.3 Shanghai Shyndec Pharmaceutical Co.,Ltd. Finasteride Oral Tablet Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.13.4 Shanghai Shyndec Pharmaceutical Co.,Ltd. Main Business Overview
    • 13.13.5 Shanghai Shyndec Pharmaceutical Co.,Ltd. Latest Developments

14 Research Findings and Conclusion

Summary:
Get latest Market Research Reports on Finasteride Oral Tablet. Industry analysis & Market Report on Finasteride Oral Tablet is a syndicated market report, published as Global Finasteride Oral Tablet Market Growth 2022-2028. It is complete Research Study and Industry Analysis of Finasteride Oral Tablet market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

Last updated on

REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$3,660.00
$7,320.00
2,829.18
5,658.36
3,407.46
6,814.92
558,845.40
1,117,690.80
308,904.00
617,808.00
Credit card Logo

Related Reports


Reason to Buy

Request for Sample of this report